Related Experiment Video
Updated: Nov 2, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.4K
Pulmonary Vein Thrombosis in COVID-19
Stephanie A Goddard1, Daniel Q Tran1, Michael F Chan1
1Department of Radiology, Tulane University Health Sciences Center, New Orleans, LA.
Chest
|June 8, 2021
Summary
COVID-19 can cause hypercoagulability, leading to rare pulmonary venous thrombosis. This case highlights an uncommon COVID-19 complication, urging increased clinical suspicion for pulmonary venous thromboembolism during hospitalization.
Area of Science:
- Pulmonology
- Cardiovascular Medicine
- Infectious Diseases
Background:
- COVID-19 is associated with a hypercoagulable state.
- Pulmonary venous thrombosis is an underreported complication of COVID-19.
- Early identification of venous thromboembolism is critical for patient outcomes.
Observation:
- A patient with COVID-19 developed an expansile filling defect in a right inferior pulmonary vein branch.
- Diagnosis was confirmed via follow-up chest CT scans.
- This finding suggests pulmonary venous thrombosis as a potential sequela of SARS-CoV-2 infection.
Findings:
- The case demonstrates pulmonary venous thrombosis in a COVID-19 patient.
- This highlights an uncommon but significant thrombotic event.
- Pulmonary venous thrombosis can occur despite anticoagulation therapy.
Implications:
- Increased clinical suspicion for pulmonary venous thrombosis in COVID-19 patients is warranted.
- Further research is needed to understand the incidence and mechanisms of pulmonary venous thrombosis in COVID-19.
- Prompt diagnosis and management of pulmonary venous thrombosis may improve patient prognosis during COVID-19 hospitalization.
Related Concept Videos
01:29Pulmonary Embolism I: Introduction
209
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
209
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
85
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
85
01:27Pulmonary Embolism III: Nursing Management
102
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
102
01:28Pulmonary Tuberculosis V
286
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
286
01:26Pulmonary Tuberculosis IV
251
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
251
01:27Pneumothorax-II
530
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
530